Genomic sequencing of DPC4 in the analysis of familial pancreatic carcinoma

被引:47
作者
Moskaluk, CA
Hruban, RH
Schutte, M
Lietman, AS
Smyrk, T
Fusaro, L
Fusaro, R
Lynch, J
Yeo, CJ
Jackson, CE
Lynch, HT
Kern, SE
机构
[1] JOHNS HOPKINS UNIV,SCH MED,DEPT ONCOL,BALTIMORE,MD 21205
[2] JOHNS HOPKINS UNIV,SCH MED,DEPT PATHOL,BALTIMORE,MD 21205
[3] JOHNS HOPKINS UNIV,SCH MED,DEPT SURG,BALTIMORE,MD 21205
[4] HENRY FORD HOSP,DEPT MED,DIV CLIN & MOL GENET,DETROIT,MI 48202
[5] CREIGHTON UNIV,SCH MED,DEPT PREVENT MED PUBL HLTH,OMAHA,NE
[6] CREIGHTON UNIV,SCH MED,DEPT PATHOL,OMAHA,NE
关键词
pancreatic cancer; DPC4; germline mutation; cancer families;
D O I
10.1097/00019606-199704000-00003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A first-degree relative with pancreatic cancer is found in 5% to 10% of patients with pancreatic carcinomas, suggesting an inherited predisposition for this neoplasm. The recently identified DPC4 tumor suppressor gene is a strong candidate for the gene responsible for the familial form of pancreatic carcinoma. DPC4 was identified in a consensus area of homozygous deletion in pancreatic carcinomas, and it is biallelically inactivated in approximately 50% of sporadic pancreatic carcinomas. The coding sequence of this gene is 1660 nucleotides in length, covering 11 exons. We describe optimized primers and conditions used in polymerase chain reaction and cycle sequencing of the entire DPC4 coding sequence of 25 individuals (eight with pancreatic carcinoma) from 11 kindreds with a familial aggregation of pancreatic carcinoma. No mutations in the coding sequences of the DPC4 gene were found; hence, it appears that germline mutations in DPC4 cannot account for many of the familial aggregations of pancreatic carcinoma.
引用
收藏
页码:85 / 90
页数:6
相关论文
共 21 条
[1]   CHROMOSOME-17 DELETIONS AND P53 GENE-MUTATIONS IN COLORECTAL CARCINOMAS [J].
BAKER, SJ ;
FEARON, ER ;
NIGRO, JM ;
HAMILTON, SR ;
PREISINGER, AC ;
JESSUP, JM ;
VANTUINEN, P ;
LEDBETTER, DH ;
BARKER, DF ;
NAKAMURA, Y ;
WHITE, R ;
VOGELSTEIN, B .
SCIENCE, 1989, 244 (4901) :217-221
[2]  
Barrett MT, 1996, CANCER RES, V56, P4351
[3]  
GHADIRIAN P, 1991, INT J PANCREATOL, V10, P183
[4]   INCREASED RISK OF PANCREATIC-CANCER IN MELANOMA-PRONE KINDREDS WITH P16(INK4) MUTATIONS [J].
GOLDSTEIN, AM ;
FRASER, MC ;
STRUEWING, JP ;
HUSSUSSIAN, CJ ;
RANADE, K ;
ZAMETKIN, DP ;
FONTAINE, LS ;
ORGANIC, SM ;
DRACOPOLI, NC ;
CLARK, WH ;
TUCKER, MA .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (15) :970-974
[5]   DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1 [J].
Hahn, SA ;
Schutte, M ;
Hoque, ATMS ;
Moskaluk, CA ;
daCosta, LT ;
Rozenblum, E ;
Weinstein, CL ;
Fischer, A ;
Yeo, CJ ;
Hruban, RH ;
Kern, SE .
SCIENCE, 1996, 271 (5247) :350-353
[6]  
Hahn SA, 1996, CANCER RES, V56, P490
[7]   GERMLINE P16 MUTATIONS IN FAMILIAL MELANOMA [J].
HUSSUSSIAN, CJ ;
STRUEWING, JP ;
GOLDSTEIN, AM ;
HIGGINS, PAT ;
ALLY, DS ;
SHEAHAN, MD ;
CLARK, WH ;
TUCKER, MA ;
DRACOPOLI, NC .
NATURE GENETICS, 1994, 8 (01) :15-21
[8]  
JEN J, 1994, CANCER RES, V54, P6353
[9]  
Kamb A, 1994, Nat Genet, V8, P23
[10]  
Kim SK, 1996, CANCER RES, V56, P2519